Overactive bladder - Which diagnostic investigations are necessary before initiating primary treatment?;Die überaktive blase ("overactive bladder syndrome") Welche diagnostik ist vor beginn der primärtherapie notwendig?

Urologe - Ausgabe A

Volumn 42, Issue 6, 2003, Pages 787-792

  Schonberger B ^a,b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Idiopathic detrusor overactivity; Overactive bladder; Urge incontinence; Urgency

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CREATININE; SPASMOLYTIC AGENT;

ARTICLE; CLINICAL EXAMINATION; DETRUSOR MUSCLE; DIAGNOSTIC TEST; ECHOGRAPHY; ECONOMIC ASPECT; HEALTH CARE COST; HUMAN; INCONTINENCE; KIDNEY; MEASUREMENT; MICROBIOLOGY; OVERACTIVE BLADDER; PATHOLOGY; QUESTIONNAIRE; RESIDUAL URINE; SYMPTOMATOLOGY; URINALYSIS; URINARY FREQUENCY; URINARY TRACT; URINARY URGENCY; UROFLOWMETRY;

BACTERIURIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMATURIA; HUMANS; KIDNEY DISEASES; MALE; MEDICAL HISTORY TAKING; MUSCLE HYPERTONIA; URINARY INCONTINENCE; URODYNAMICS;

EID: 0038608527     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-003-0362-z     Document Type: Article

References (36)

1. Abrams P, Cardozo L, Fall M et al. (2002) The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Contincence Society. Neurourol Urodyn 21: 167-178
2. Abrams P, Kelleher CJ, Kerr LA, Rogers RG (2000) Overactive bladder significantly affects quality of life. Am J Manag Care 6 (Suppl 11): 580-590
3. Abrams P, Larsson G, Chapple C, Wein AJ (1999) Factors involved in the success of antimuscarinic treatment. BJU Int 83 (Suppl 2) 42-47
4. Abrams P, Wein AJ (1998) Die instabile Blase- eine verbreitete und behandelbare Erkrankung. Erik Sparre Medical AB, Stockholm
5. Abrams P, Wein AJ (2000) Introduction: Overactive bladder and its treatment. Urology 55:1-2
6. Ahlberg J, Edlund CH, Wikkelsö C, Rosengren L, Fall M (2002) Neurological signs are common in patients with urodynamically verified "idiopathic" bladder overactivity. Neurourol Urodyn 21: 65-70
7. Alloussi S, Schönberger B, Mürtz G et al. (2000) Behandlung des Urge-Syndroms mit Propiverin in der therapeutischen Praxis. Urologe B 40: 367-373
8. Bavendam TG (2000) Urinary frequency and urgency. In: LENTZ GM (ed) Urogynecology. Arnold, London/ Oxford University Press, New York
9. Blaivas JG (2002) Overactive bladder revisited (Editorial) Neurourol Urodyn 21: 523
10. Blaivas JG (2003) Urodynamics (Editorial) Neurourol Urodyn 22: 91
11. Digesu GA, Khullar V, Cardozo L, Salvatore S (2003) Overactive bladder symptoms: Do we need urodynamics? Neurourol Urodyn 22: 105-108
12. FALL M. Kommentar zu FLISSER et al. (2003) J Urol 169: 533-534
13. Fitzgerald MP, Brubaker L (2002) Urinary incontinence symptom score and urodynamic diagnosis. Neurourol Urodyn 21: 30-35
14. Fitzgerald MP, Brubaker L (2003) Variability of 24-hour voiding diary variables among asymptomatic women. J Urol 169: 207-209
15. Flisser AJ, Walmsley K, Blaivas JG (2003) Urodynamic classification of patients with symptoms of overactive bladder. J Urol 169: S29-S33
16. Graham CW, Mochowski D (2002) Questionnaires for women with urinary symptoms. Neurourol Urodyn 21: 473-481
17. Homma Y, Ando T, Yoshida M et al. (2002) Voiding and incontinence frequencies: variability of diary data and required diary length. Neurourol Urodyn 21: 204-209
18. Hu T-W, Wagner TH (2000) Economic considerations in overactive bladder. Am J Manag Care 6 (Suppl 11): 591-598
19. Madersbacher H, Halaska M, Voigt R, Alloussi S, Höfner K (1999) Placebokontrollierte multizentrische Studie zum Vergleich der Verträglichkeit und Wirksamkeit von Propiverin und Oxybutynin bei Patienten mit Urge-Symptomatik und Urge-Inkontinenz (Übersetzung). BJU Int 84: 646-651
20. Madersbacher S, Pycha A, Klingler C, Schatzl G, Marberger M (1999) The International Prostate Score in both sexes: a urodynamics-based comparison. Neurourol Urodyn 18:173-182
21. Malone-Lee J (2000) Overactive bladder: defining the disease (discussion). Am J Manag Care 6 (Suppl 11): 609
22. McGuire EJ (2000) Mixed symptomatology. BJU Int 85 (Suppl 3): 47-52
23. Moore KH, Simons A, Mukerjee C, Lynch W (2000) The relative incidente of detrusor instability and bacterial cystitis detected on the urodynamic-test day. BJU Int 85:786-792
24. Nitti VW, Ficazzola M (2000) Voiding dysfunction diagnostic evaluation. In: Appel RA (ed) Voiding dysfunction. Humana Press, Totowa/NJ, pp 25-60
25. Oelke M, Höfner K, Wiese B, Diddens H, Jonas U (2001) Neues Nomogramm zur nichtinvasiven Diagnostik der Blasenauslassobstruktion. Abstrakts, Forum Urodynamicum, Graz 15.-17.03.2001
26. Palmtag H, Goepel M, Heidier H et al. (2003) Urodynamik. Springer, Berlin Heidelberg New York Tokio (im Druck)
27. Pel JJ, Bosch JL, Blom JA et al. (2002) Development of a non-invasive strategy to classify bladder outlet obstruction in male patients with LUTS. Neurourol Urodyn 21: 177-125
28. Reynard JM, Yang Q, Donovan JL et al. (1998) The ICSBPH-Study: Uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. BJU 82/5: 619-662
29. Schäfer W, Abrams P, Liao L et al. (2002) Good urodynamic practices: uroflowmetry filling cystometry, and pressure-flow studies. Neurourol Urodyn 21: 261-274
30. Schick E,Jolivet-Tremblay M, Dupont C, Bertrand PE, Tessier J (2003) Frequency-volume chart: The minimum number of days required to obtain reliable result. Neurourol Urodyn 22/2: 92-96
31. Soligo M, Salvatore S, Khullar V et al. (2002) Overactive bladder definition and ultrasound measurement of bladder wall thickness: The right way without urodynamics. Neurourol Urodyn 21: 284-285
32. Thomas AW, Abrams P (2000) Lower urinary tract symptoms, benign prostatic obstruction and the overactive bladder. BJU Int (Suppl 3): 57-68
33. Van Kerrebrock P, Kreder K, Jonas U et al. (2001) Tolterodine once-daily: Superior efficacy and tolerability in the treatment of the overactive bladder. Urology 57: 414-421
34. Van Venrooij GE, Eckhardt MD, Gisolf KW, Boon TA (2002) Data from frequency-volume charts versus filling cystometric estimated capacities and prevalence of instability in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Neurourol Urodyn 21:106-111
35. Wadie BS, Ebrahim EE, Gomha MA (2002) The relationship of detrusor instability and symptoms with objective parameters used for diagnosing bladder outlet obstruction: A prospective study. J Urol 168: 132-134
36. Wein AJ (2000) Overactive bladder: defining the disease. Am J Manag Care 6 (Suppl 11): 5S9-564